longbridge

Valneva SE

VALN
----

All Shareholders

Shareholder Type

  • Public and others65.63%
  • Institutions24.72%
  • VC/PE firms5.04%
  • Private companies3.30%
  • Individuals & Insiders1.31%

Major Shareholders

Major Shareholders Latest
Shareholder
Pfizer Venture Investments LLC
5.04%9.55M0.46%+0
Frazier Life Sciences Management, LP
4.35%8.25M1.71%+3.67M
The Goldman Sachs Group, Inc.
4.13%7.83M--+7.83M
Bpifrance Participations SA
3.77%7.16M0.55%-356.00K
Groupe Grimaud La Corbière SA
3.30%6.25M0.30%+0
Braidwell LP
2.85%5.40M0.26%+0
CDC Croissance
2.51%4.76M0.32%-159.65K
Candriam, Société En Commandite Par Actions
1.82%3.45M0.17%+0
Polar Capital Holdings Plc
1.66%3.15M0.15%+0
General American Investors Company, Inc.
0.98%1.86M0.09%+0
Vivo Capital, LLC
0.80%1.53M--+1.53M
Norges Bank Investment Management
0.68%1.29M0.06%-1.56K
Amundi Asset Management SAS
0.64%1.22M0.12%-218.16K
Thomas LingelbachPresident, CEO & Director
0.60%1.13M0.05%+0
C WorldWide Asset Management Fondsmaeglerselskab A/S
0.42%800.00K--+800.00K
BlackRock, Inc.
0.37%701.38K0.93%-1.77M
Syquant Capital SAS
0.29%549.90K0.04%-22.65K
ODDO BHF Asset Management SAS
0.25%473.05K0.02%+0
Peter BuhlerChief Financial Officer
0.21%388.90K0.02%+0
Juan-Carlos JaramilloChief Medical Officer
0.18%345.56K0.02%+0
© 2026 Longbridge｜Terms of ServicePrivacy Policy